Anbio Biotechnology (NNNN)

NASDAQ: NNNN · Real-Time Price · USD

25.75

+1.14 (4.63%)

Mar 31, 2026, 12:22 PM EDT - Market open

Anbio Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,130	-	-	-	-
Market Cap Growth	260.14%	-	-	-	-
Enterprise Value	1,067	0	0	0	0
Net Debt / Equity Ratio	-0.49	-0.68	-0.65	-0.69	-1.65
Net Debt / EBITDA Ratio	-7.61	-5.89	-4.91	-0.85	-1.70
Net Debt / FCF Ratio	-	-5.65	-10.78	-1.95	-1.00
Asset Turnover	0.30	0.47	0.45	2.49	0.90
Inventory Turnover	-	-	18.94	62.06	-
Quick Ratio	130.75	7.41	11.65	6.14	2.06
Current Ratio	211.10	10.71	15.86	9.88	2.07
Return on Equity (ROE)	11.51%	14.83%	16.47%	132.75%	100.00%
Return on Assets (ROA)	7.57%	11.49%	13.17%	108.04%	49.96%
Return on Invested Capital (ROIC)	17.89%	36.84%	42.73%	748.12%	-212.54%
Return on Capital Employed (ROCE)	7.89%	12.47%	14.33%	135.19%	96.85%
Buyback Yield / Dilution	-1.37%	-97.30%	-21435216.00%	0.00%	-
Total Shareholder Return	-1.37%	-97.30%	-21435216.00%	0.00%	-

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q